Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
News|Poll|March 27, 2015
Oral Anticoagulation: Would You Recognize a Candidate?
Author(s)Payal Kohli, MD, FACC
What does the patient with atrial fibrillation who would benefit from oral anticoagulation look like today? Q & A, here.
Advertisement
The “face” of the patient with atrial fibrillation (AF) who will benefit from some level of anticoagulation therapy is changing. The most recent change in look is a result of updated guidelines put forth by the American Heart Association, American College of Cardiology, and Heart Rhythm Society in 2014.
Which of the following are current guideline recommendations for oral anticoagulation in patients with atrial fibrillation?
Advertisement
Related to this article
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
The FDA approved an autoinjector device for lerodalcibep-liga and an updated indication reflecting cardiovascular risk reduction.
Advertisement
Advertisement
Trending on Patient Care Online
1
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
2
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
The Shift From Off-Label Use to On-Label Agitation Therapy
5